AstraZeneca
AZN
#69
Rank
NZ$424.65 B
Marketcap
NZ$273.82
Share price
0.88%
Change (1 day)
15.14%
Change (1 year)

EPS for AstraZeneca (AZN)

EPS in 2026 (TTM): NZ$11.96

According to AstraZeneca's latest financial reports the company's current EPS (TTM) is NZ$11.79. In 2024 the company made an earnings per share (EPS) of NZ$7.70 an increase over its 2023 EPS that were of NZ$6.51.

EPS history for AstraZeneca from 2011 to 2026

Annual EPS

Year EPS Change
2026 (TTM)NZ$11.96
2024NZ$7.7018.23%
2023NZ$6.5181.13%
2022NZ$3.60631.03%
2021NZ$0.49-88.11%
2020NZ$4.14136.89%
2019NZ$1.75-39.41%
2018NZ$2.88-28.27%
2017NZ$4.02-14.37%
2016NZ$4.6924.11%
2015NZ$3.78127.55%
2014NZ$1.66-51.96%
2013NZ$3.46-58.95%
2012NZ$8.43-32.2%
2011NZ$12.43

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
NZ$14.82 25.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$11.91 1.01%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
NZ$2.22-81.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
NZ$6.12-48.08%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
NZ$47.88 306.12%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
NZ$4.34-63.17%๐Ÿ‡ซ๐Ÿ‡ท France
Biogen
BIIB
NZ$15.86 34.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$6.06-48.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$6.04-48.78%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
NZ$6.59-44.08%๐Ÿ‡ฌ๐Ÿ‡ง UK